Literature DB >> 20981697

Response of infantile hepatic hemangioma to propranolol resistant to high-dose methylprednisolone and interferon-α therapy.

Faik Sarialioglu, Ayse Erbay, Senay Demir.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20981697     DOI： 10.1002/pbc.22691

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  9 in total

1.  Hepatic hemangioendothelioma of infancy: clinical features of a large cohort of patients and proposed management.

Authors:  Loredana Sana; Pietro Betalli; Michela Bravi; Paola Stroppa; Maurizio Cheli; Aurelio Sonzogni; Lisa Licini; Roberto Agazzi; Michele Colledan; Filippo Parolini; Daniele Alberti; Lorenzo D'Antiga
Journal:  Pediatr Surg Int       Date:  2021-01-29       Impact factor: 1.827

Review 2.  Multifocal infantile hepatic hemangiomas--imaging strategy and response to treatment after propranolol and steroids including review of the literature.

Authors:  Thangamadhan Bosemani; Katherine B Puttgen; Thierry A G M Huisman; Aylin Tekes
Journal:  Eur J Pediatr       Date:  2012-01-11       Impact factor: 3.183

Review 3.  Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches.

Authors:  Brittany G Craiglow; Richard J Antaya
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

Review 4.  History of the infantile hepatic hemangioma: From imaging to generating a differential diagnosis.

Authors:  Maria Gnarra; Gerald Behr; Alison Kitajewski; June K Wu; Sudha A Anupindi; Carrie J Shawber; Nick Zavras; Dimitrios Schizas; Chris Salakos; Konstantinos P Economopoulos
Journal:  World J Clin Pediatr       Date:  2016-08-08

Review 5.  Initiation and use of propranolol for infantile hemangioma: report of a consensus conference.

Authors:  Beth A Drolet; Peter C Frommelt; Sarah L Chamlin; Anita Haggstrom; Nancy M Bauman; Yvonne E Chiu; Robert H Chun; Maria C Garzon; Kristen E Holland; Leonardo Liberman; Susan MacLellan-Tobert; Anthony J Mancini; Denise Metry; Katherine B Puttgen; Marcia Seefeldt; Robert Sidbury; Kendra M Ward; Francine Blei; Eulalia Baselga; Laura Cassidy; David H Darrow; Shawna Joachim; Eun-Kyung M Kwon; Kari Martin; Jonathan Perkins; Dawn H Siegel; Robert J Boucek; Ilona J Frieden
Journal:  Pediatrics       Date:  2012-12-24       Impact factor: 7.124

Review 6.  The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies.

Authors:  Yin Lou; Wen-jia Peng; Yi Cao; Dong-sheng Cao; Juan Xie; Hong-hong Li
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

7.  New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma.

Authors:  Ilknur Kozanoglu; Melis Kartal Yandim; Zeynep Birsu Cincin; Hakan Ozdogu; Bedia Cakmakoglu; Yusuf Baran
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-19       Impact factor: 4.553

8.  Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma.

Authors:  Jessica M Stiles; Clarissa Amaya; Steven Rains; Dolores Diaz; Robert Pham; James Battiste; Jaime F Modiano; Victor Kokta; Laura E Boucheron; Dianne C Mitchell; Brad A Bryan
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

9.  Neonatal giant hepatic hemangioma: A case report.

Authors:  Zhenwei Zhu; Peng Cai; Jie Zhu; Jianlei Chen; Bin Wu; Zhicheng Gu; Shungen Huang; Jian Wang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.